Infertile men had lower endocannabinoid levels and altered cannabinoid system in their sperm
Sperm from infertile men showed markedly reduced endocannabinoid levels (both anandamide and 2-AG) and altered enzyme ratios compared to fertile men, with TRPV1 receptor binding undetectable in infertile sperm.
Quick Facts
What This Study Found
Researchers compared the endocannabinoid system in sperm from fertile and infertile men. Infertile men had markedly reduced levels of both anandamide (AEA) and 2-AG in their seminal plasma. The ratio of degradation to synthesis enzymes was increased in infertile sperm, meaning endocannabinoids were being broken down faster relative to production.
Vanilloid receptor (TRPV1) binding was detectable in fertile sperm but completely undetectable in infertile sperm, while CB1 and CB2 receptor levels did not differ between groups. Since TRPV1 is involved in capacitation and the acrosome reaction (key steps in fertilization), its absence in infertile sperm pointed to a specific functional defect.
The authors suggested these endocannabinoid system alterations could serve as biomarkers for male infertility and as targets for new treatments.
Key Numbers
Reduced AEA and 2-AG in infertile seminal plasma. Increased degradation:biosynthesis enzyme ratios. TRPV1 binding: detectable in fertile, undetectable in infertile sperm. CB1 and CB2: no difference.
How They Did This
Cross-sectional comparison of sperm from fertile and infertile men. Measured endocannabinoid content (LC-ESI-MS), enzyme mRNA and protein expression (qRT-PCR, Western Blot, ELISA), enzyme activity, and receptor binding (CB1, CB2, TRPV1).
Why This Research Matters
Male infertility affects many couples, and the endocannabinoid system's role was previously unappreciated. This study identified specific molecular targets that could lead to new diagnostic tests and treatments for male reproductive problems.
The Bigger Picture
This connected cannabis research to reproductive medicine. Since exogenous cannabinoids from cannabis use affect the same system, these findings raised questions about whether cannabis use could impair fertility by disrupting the delicate endocannabinoid balance in sperm.
What This Study Doesn't Tell Us
Cross-sectional design cannot determine whether endocannabinoid changes cause or result from infertility. Did not control for cannabis use by study participants. Sample sizes were not specified in the abstract. The functional significance of the TRPV1 finding requires validation.
Questions This Raises
- ?Does cannabis use impair male fertility by disrupting sperm endocannabinoid balance?
- ?Could endocannabinoid-targeting drugs treat male infertility?
- ?Can TRPV1 status serve as a clinical biomarker for fertility assessment?
Trust & Context
- Key Stat:
- TRPV1 receptor: present in fertile sperm, absent in infertile sperm
- Evidence Grade:
- Cross-sectional molecular study with comprehensive endocannabinoid system profiling. Novel findings but cannot determine causal direction.
- Study Age:
- Published in 2012. The endocannabinoid system's role in reproduction has been studied further, with implications for cannabis users trying to conceive.
- Original Title:
- Differences in the endocannabinoid system of sperm from fertile and infertile men.
- Published In:
- PloS one, 7(10), e47704 (2012)
- Authors:
- Lewis, Sheena E M(2), Rapino, Cinzia(3), Di Tommaso, Monia, Pucci, Mariangela, Battista, Natalia, Paro, Rita, Simon, Luke, Lutton, Deborah, Maccarrone, Mauro
- Database ID:
- RTHC-00581
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Could cannabis use affect male fertility?
This study found the endocannabinoid system plays a critical role in sperm function. Since cannabis introduces external cannabinoids that interact with this system, it raises the possibility that cannabis use could disrupt sperm function. However, this study compared fertile vs infertile men, not cannabis users vs non-users.
What is TRPV1 and why does it matter for fertility?
TRPV1 is a receptor involved in capacitation (preparing sperm for fertilization) and the acrosome reaction (penetrating the egg). Its complete absence in infertile sperm suggests it plays an essential role in successful fertilization.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-00581APA
Lewis, Sheena E M; Rapino, Cinzia; Di Tommaso, Monia; Pucci, Mariangela; Battista, Natalia; Paro, Rita; Simon, Luke; Lutton, Deborah; Maccarrone, Mauro. (2012). Differences in the endocannabinoid system of sperm from fertile and infertile men.. PloS one, 7(10), e47704. https://doi.org/10.1371/journal.pone.0047704
MLA
Lewis, Sheena E M, et al. "Differences in the endocannabinoid system of sperm from fertile and infertile men.." PloS one, 2012. https://doi.org/10.1371/journal.pone.0047704
RethinkTHC
RethinkTHC Research Database. "Differences in the endocannabinoid system of sperm from fert..." RTHC-00581. Retrieved from https://rethinkthc.com/research/lewis-2012-differences-in-the-endocannabinoid
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.